Navigation Links
Enrollment Completed in Regeneron and Bayer HealthCare Phase 3 Studies of VEGF Trap-Eye in Neovascular Age-Related Macular Degeneration (Wet AMD)
Date:9/14/2009

AMD, vision is not improved or stabilized in all patients despite monthly office visits and examinations that are inconvenient for these often elderly patients," said George D. Yancopoulos, M.D., Ph.D., President of Regeneron Research Laboratories. "This Phase 3 program is exploring various doses and dosing schedules with our novel anti-VEGF investigational agent to evaluate whether further improvements in vision and/or longer dosing intervals than monthly administration are possible."

About the VIEW Program

The VIEW 1 study is being conducted in the United States and Canada by Regeneron and the VIEW 2 study is being conducted in Europe, Asia Pacific, Japan, and Latin America by Bayer HealthCare. In the first year of the studies, the safety and efficacy of VEGF Trap-Eye at doses of 0.5 mg and 2.0 mg administered at four-week intervals and 2.0 mg at an eight-week dosing interval following one additional 2.0 mg dose at week four are being evaluated. Patients randomized to the ranibizumab arm of the trial will receive a 0.5 mg dose every four weeks. After the first year of treatment, patients will continue to be followed and treated for another year on a flexible, criteria-based extended PRN regimen with a dose administered at least every 12 weeks, but not more often than every four weeks until the end of the study.

The primary endpoint of these non-inferiority studies is the proportion of patients treated with VEGF Trap-Eye who maintain vision at the end of one year, compared to ranibizumab patients. Visual acuity is defined as the total number of letters read correctly on the Early Treatment Diabetic Retinopathy Study (ETDRS) chart, a standard chart used in research to measure visual acuity. Maintenance of vision is defined as losing fewer than three lines (equivalent to 15 letters) on the ETDRS chart. Key secondary endpoints include the mean change from baseline in visual acuity as measured by ETDRS and
'/>"/>

SOURCE Regeneron Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. R-Tech Ueno Completes Subject Enrollment in Phase 2 Clinical Study of 0.15% UF-021
2. Roskamp Institute Announces Enrollment of First Students to Participate in its Innovative Research Doctorate Program
3. MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
4. Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
5. Enrollment in Delcaths Pivotal Phase III Metastatic Melanoma Clinical Trial Achieves Seventy-Five Percent Accrual
6. Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial
7. TargeGen Announces Successful Completion of Patient Enrollment in Clinical Trial of JAK2 Inhibitor TG101348 in Myelofibrosis Patients and Scheduled Presentation of Preliminary Trial Data at EHA Conference in Berlin
8. InspireMD Announces the Enrollment of the 1st Patient in the MGuard iMOS Registry, the Registry Will Enroll 1000 Patients
9. Peregrine Pharmaceuticals Completes Patient Enrollment in its Phase II Trial of Bavituximab Plus Docetaxel in Breast Cancer Patients
10. Video: ev3 Inc. Announces First Patient Enrollments in DEFINITIVE LE Post-Market Study
11. Intarcia Therapeutics, Inc. Announces Completion of Enrollment of ITCA 650 Phase 1b Study for the Treatment of Type 2 Diabetes
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/23/2014)... Therapeutics, Inc. (NASDAQ: ECTE ), a ... believes that its current liquidity is insufficient to ... has suspended its product development, research, manufacturing and ... and capital resources. The actions ... position, funding alternatives, and projected product development costs ...
(Date:9/23/2014)... , Sept. 23, 2014 Ultrasound devices ... body in order to diagnose diseases and also ... surgical instruments while performing surgeries. This report studies ... parameters such as product type, technologies, applications and ... market, based on the product type has been ...
(Date:9/23/2014)... Sept. 23, 2014 Nuclear medicine market ... Radiopharmaceuticals/ Nuclear are drugs that contain ... field to diagnose and treat diseases. ... awareness for radiopharmaceuticals, and ready availability of radiopharmaceuticals ... Furthermore, increased public awareness and use of SPECT ...
Breaking Medicine Technology:Echo Therapeutics Suspends Operations To Conserve Liquidity 2Echo Therapeutics Suspends Operations To Conserve Liquidity 3Echo Therapeutics Suspends Operations To Conserve Liquidity 4Ultrasound Devices Market (By Product Type, By Technology and By Application - Obstetrics and Gynecology, Cardiovascular, Abdominal and Others) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019 2Ultrasound Devices Market (By Product Type, By Technology and By Application - Obstetrics and Gynecology, Cardiovascular, Abdominal and Others) - Global Industry Analysis, Size, Share, Growth, Trends & Forecast, 2013 - 2019 3Global Nuclear Medicine Market - Growth, Trends & Forecasts (2014-2019) 2
...  A consortium comprised of investment funds advised by Apax ... Plan Investment Board ("CPPIB") and the Public Sector Pension ... Kinetic Concepts, Inc. (NYSE: KCI ) have ... common share in cash, or a total value of ...
... 2011 DMC Harper University Hospital is the ... Myriad™, for brain tumor removal.  This one of a kind ... that their previously inoperable or hard to reach brain tumors ... is an automated, non-heat producing surgical device that removes tumor ...
Cached Medicine Technology:Kinetic Concepts Shareholders Approve Acquisition by Apax Partners, CPPIB and PSP Investments 2Kinetic Concepts Shareholders Approve Acquisition by Apax Partners, CPPIB and PSP Investments 3Kinetic Concepts Shareholders Approve Acquisition by Apax Partners, CPPIB and PSP Investments 4DMC Harper University Hospital is the First in Michigan to Utilize New Device for Brain Tumor Removal 2
(Date:9/23/2014)... (PRWEB) September 23, 2014 Mel Frank, ... about cultivating, growing and harvesting marijuana. He is perhaps ... the field and he’ll be leading a special elective ... am to 5:00 pm at Oaksterdam University ... law, botany and nomenclature, harvesting and manicuring, and identifying ...
(Date:9/23/2014)... Mo. Infants, vocalizations throughout the first year ... and cooing to forming syllables and first words. ... amount of vocalizations may differ between hearing and ... that infant vocalizations are primarily motivated by infants, ... with profound hearing loss who received cochlear implants ...
(Date:9/23/2014)... PA (PRWEB) September 23, 2014 "The primary ... infection control," said an inventor from Sacramento, Ca.. "Call lights ... bedding or left hanging on the IV pole out of ... have the nurse call device whenever they need it, I ... to effectively position the nurse call device within easy reach. ...
(Date:9/23/2014)... TO CONVENE PATHWAYS TO PREVENTION WORKSHOP: ROLE OF OPIOIDS ... WHAT: , The National Institutes of Health is convening ... scientific evidence on the long-term effectiveness and potential risks ... among the nation,s top experts in the field of ... well as key NIH scientists who focus on pain ...
(Date:9/23/2014)... September 23, 2014 World of Home ... philanthropic support. Most recently, the gym has been raising ... Fitness program. Throughout the year, World of Home Fitness ... charitable causes. , Over the summer, World of Home ... Through their Ageless Fitness program, participants helped feed seniors ...
Breaking Medicine News(10 mins):Health News:Special Elective Course Added to Oaksterdam University Schedule; Unique Opportunity to Learn From the “Godfather of Cannabis” Mel Frank on September 27, 2014 2Health News:Infant cooing, babbling linked to hearing ability, MU researcher finds 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 2Health News:NIH Pathways to Prevention Workshop: The Role of Opioids in the Treatment of Chronic Pain 3Health News:World of Home Fitness Supports Meals on Wheels 2
... Feb. 25 Francesco Federico, M.D., president ... today the completion of an affiliation between ... Medical Group, Inc., and Verdugo Hills Medical ... (IPAs).(Logo: http://www.newscom.com/cgi-bin/prnh/20081112/LAW052LOGO )Verdugo Hills Medical Group ...
... deformity due to wrong size shoesLAS VEGAS, Feb. 25 ... according to a new study presented today at the 2009 ... ( http://www.aaos.org/ ) (AAOS). As a result, these children ... study, which took place in Switzerland, included nearly 250 boys ...
... sports affects healing time for ACL injuries in young ... 300,000 Anterior Cruciate Ligament (ACL) tears occur in the ... the 2009 Annual Meeting of the American Academy ... tears are being seen in younger patients as an ...
... Two compounds developed by Northwestern University chemists have ... in protecting against cerebral palsy, a condition caused ... coordination. , "The results were just stunning, absolutely ... of Chemistry in the Weinberg College of Arts ...
... , The countries of Central Africa have joined forces ... clinical trials under best practices. CANTAM (Central Africa Network on ... is the first EDCTP-funded regional Network of Excellence to prepare ... supported by a EUR 3 million grant for the duration ...
... Va., Feb. 25 The National Hospice and Palliative ... its "Reaching Out" grants. Funded by the Department of ... access to hospice and palliative care services for rural ... providers that represent a range of community-based organizations. ...
Cached Medicine News:Health News:Lakeside Community Healthcare Continues Growth With Verdugo Hills Medical Group IPA Affiliation 2Health News:If the Shoe Fits...or Does It? 2Health News:If the Shoe Fits...or Does It? 3Health News:An Athlete's First Question: 'Doc, When Can I Return?' 2Health News:An Athlete's First Question: 'Doc, When Can I Return?' 3Health News:Stunning finding: Compounds protect against cerebral palsy 2Health News:Stunning finding: Compounds protect against cerebral palsy 3Health News:Stunning finding: Compounds protect against cerebral palsy 4Health News:CANTAM first African Network of Excellence for clinical trials 2Health News:Grants to Increase Access to Hospice and Palliative Care for Rural and Homeless Veterans Awarded by National Hospice and Palliative Care Organization 2
... workmanship are the hallmark of these stereozoom ... mind. The top (incident) circular 9W fluorescent ... while remaining cool to the touch. Binocular ... 10x to 44x zoom magnification or high-power ...
... system expandability: the first inverted microscope to ... infinity space. Multi-port design enables optical input/output ... variety of illumination and detector equipment. Extendable ... an optional light source and other attachments ...
... Megapixel color imaging camera system designed ... high performance, megapixel digital cameras provides ... view them on a PC via ... This "live" previewing capability is accompanied ...
... camera with direct digital output. Three-chip color ... Olympus wide array of high-quality color video ... and flexibility you need for an efficient ... high-resolution, real-time image of your specimen that ...
Medicine Products: